Cytochrome P450 2A6 and 2B6 polymorphisms and smoking cessation success in patients treated with varenicline.

Paulo Roberto Xavier TomazMariana Soares KajitaJuliana Rocha SantosJaqueline ScholzTânia Ogawa AbePatrícia Viviane GayaJosé Eduardo KriegerAlexandre Costa PereiraPaulo Caleb Júnior Lima Santos

Published in: European journal of clinical pharmacology (2019)

CYP2B6 rs8109525 was associated with a higher success rate of smoking cessation with varenicline treatment. This finding may be useful in pharmacogenomic strategies for smoking cessation therapy.

Keyphrases

smoking cessation
replacement therapy
stem cells
clinical decision support
mesenchymal stem cells